-
DAC_RNA-seq of murine osteosarcoma cell line genetically modified for CYR61
Dac
EGAC50000000352
-
Spatial atlas of diffuse large B-cell lymphoma
Dataset
EGAD50000002927
-
Spatial atlas of diffuse large B-cell lymphoma
Dataset
EGAD50000002928
-
Cell-Free DNA Fragmentation Distinguish Immunotherapy Responders from Non- Responders in Head and Neck Cancer: A Multi-Institute Prospective Study
Study
EGAS50000001286
-
Genetic, epigenetic and fragmentomic profiling of plasma cell-free DNA in cancer patients
Study
EGAS50000002022
-
Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution
Study
EGAS50000002011
-
Dataset related to ""Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution"
Dataset
EGAD50000002898
-
The Precision Medicine in Liver Cancer across an Asia-pacific NETwork (PLANET) – HCC recurrence cohort
Study
EGAS50000000869
-
Single-nuclei RNAseq of normal human choroid and uveal melanoma
Study
EGAS00001004955
-
Single-nuclei RNAseq of normal human choroid and uveal melanoma
Dataset
EGAD50000002941
-
A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity
Dataset
EGAD00001015516
-
Transcriptional alterations induced by BET inhibitor and Omaveloxolone combination in acute myeloid leukemia cells
Dataset
EGAD00010002852
-
Clinical Outcomes of 344 Diffuse Large B-Cell Lymphoma patients
Study
EGAS50000001054
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505
-
IMMUcan SCCHN1 cohort
Study
EGAS50000001533
-
Whole-genome sequencing study of uveal melanoma
Study
EGAS50000001603
-
Evaluation Of The Role Of Tumor Mutational Burden As A Prognostic Biomarker In Follicular Lymphoma
Study
EGAS50000001448
-
A New CA19-9 Cut-Off Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC
Study
EGAS50000001575
-
A Comparative Analysis of Illumina, Element Biosciences, and Ultima Genomics Platforms for Liquid Biopsy Applications in Pancreatic Ductal Adenocarcinoma
Study
EGAS50000002029
-
Count Matrix of Bulk RNA-sequencing of POLARIX Clinical Trial
Dataset
EGAD50000002479
-
Whole-exome and RNA-seq sequencing of HCC of metastatic and de novo origin
Study
EGAS50000002057
-
Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)
Study
EGAS00001007469
-
RNA-sequencing of HCC of metastatic and de novo origin
Dataset
EGAD50000002957
-
Whole-exome sequencing of HCC of metastatic and de novo origin
Dataset
EGAD50000002958
-
Follicular Lymphoma Whole Genome and Transcriptome Sequencing
Study
EGAS00001006646
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Single-cell whole-genome sequencing reveals convergent evolution in Burkitt lymphoma
Study
EGAS50000001681
-
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
Study
EGAS00001004469
-
Container Study for ICGC Malignant Lymphoma Master Study (MMML)
Study
EGAS00001001600
-
IDH1 Somatic Mutation Profile in Intrahepatic Cholangiocarcinoma
Study
EGAS50000001638
-
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.
Study
EGAS50000001722
-
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Study
EGAS50000000932
-
Patient-derived organoids as predictive models for drug testing and repurposing in glioblastoma therapy
Study
EGAS50000001221
-
Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups
Study
EGAS50000001964
-
Cellular Analysis of Resistance and Evolution (CARE) IDH-mutant glioma dataset
Study
EGAS50000001727
-
Whole exome sequencing of mesothelioma FFPE tumors and paired samples.
Study
EGAS50000001813
-
Mitochondrial peroxiredoxin 3 is a tractable cancer therapeutic target modulated by SLC7A11
Study
EGAS50000001827
-
The whole genome landscape of Burkitt lymphoma subtypes
Study
EGAS00001003778
-
Single-cell profiling reveals mechanisms of response to anti-PD-L1 versus anti-PD-L1 combined with anti-CTLA4 in head and neck squamous cell carcinoma
Study
EGAS50000000037
-
Accelerated single cell seeding in relapsed multiple myeloma
Study
EGAS00001004404
-
High-depth whole genome sequencing of 51 premalignant breast lesions
Study
EGAS50000001436
-
DCIS fresh frozen fragmentomics dataset
Study
EGAS50000001475
-
High-depth whole genome sequencing of 26 premalignant breast lesions
Study
EGAS50000001559
-
Tremelimumab +/- durvalumab in combination with paclitaxel as immune induction in metastatic urothelial cancer: clinical and translational results of the ICRA trial
Study
EGAS50000001574
-
ABO: a 3D stroma-supported culture platform enabling full human B lymphopoiesis for disease modeling and gene therapy development
Study
EGAS50000001693
-
A prognostic human brain network for diffuse midline glioma
Study
EGAS50000001752
-
Targeting vulnerabilities in IDH mutant tumours: The model matters WES study
Study
EGAS50000001870
-
RNAseq of medulloblastoma data (MB_COMICS cohort)
Study
EGAS50000000410
-
Methylome of medulloblastoma data (MB_COMICS cohort)
Study
EGAS00001007815
-
Spatial Transcriptomics Uncovers Tumor Microenvironment-Based Subtypes in Invasive Lobular Carcinoma
Study
EGAS50000001001